Tag Archives: Federal Circuit

In Re Hubbell

Guest post by Theresa Stadheim of Schwegman Lundberg & Woessner) In In Re Jeffrey Hubbell, Jason Schense, Andreas Zisch, and Heike Hall, Appeal No. 2011-1547 (Fed. Cir. March 7, 2013) (a copy can be found at the end of this post), … Continue reading

Posted in Double Patenting | Tagged , , , , , , , , , , , | Leave a comment

Federal Circuit Will Review Cybor Decision En Banc

On March 15th, in a long-awaited ruling, the Fed. Cir. vacated a panel holding reversing a lower court’s finding that disputed means-plus-function claims met the written description requirement. The Fed. Cir. asked the parties and amici (and there will be … Continue reading

Posted in Claim Interpretation | Tagged , , , , | Leave a comment

Brilliant Instruments v. GuideTech – Doctrine of Equivalents on Review

Contributed by Theresa Stadheim of Schwegman Lundberg & Woessner In Brilliant Instruments, Inc., v. Guidetech, LLC, Appeal no. 2012-1018 (Fed. Cir. February 20, 2013) (a copy can be found at the end of this post), a panel of the Federal … Continue reading

Posted in Claim Interpretation, Doctrine of Equivalents | Tagged , , , , , , , , | Leave a comment

Time For Myriad To Fight Another Day

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments